Neurons from the brain amplify touch sensation. Could they be targeted to treat neuropathic pain?

neuropathic pain amplification circuit

Neuropathic pain is a hard-to-treat chronic pain condition caused by nervous system damage. For people affected, the lightest touch can be intensely painful. A study in today’s Nature may open up a new angle on treatment — and could help explain why mind-body techniques can sometimes help people manage their pain.

“We know that mental activities of the higher brain — cognition, memory, fear, anxiety — can cause you to feel more or less pain,” notes Clifford Woolf, MB, BCh, PhD, director of the F.M. Kirby Neurobiology Center at Boston Children’s Hospital. “Now we’ve confirmed a physiological pathway that may be responsible for the extent of the pain. We have identified a volume control in the brain for pain — now we need to learn how to switch it off.”

The study demonstrates that a small group of neurons that originate in the brain’s somatosensory cortex can influence sensitivity to touch and, in a neuropathic pain model, amplify pain sensation. These cortical neurons send projections to the spinal cord’s dorsal horns, which receive touch information from the body.

“The anatomy of this circuit has been known for some time,” notes Zhigang He, PhD of the Kirby Center, who was co-senior author on the paper with Woolf and Kuan Hong Wang, PhD, of the National Institute of Mental Health (NIMH). “But no one actually looked at its function before.”

Influencing pain “volume,” from above

Woolf, He and colleagues combined a mouse model of neuropathic pain with recently developed technologies to visualize and target specific groups of neurons in the brain and spinal cord. This enabled them to observe which circuits were activated when mice were exposed to noxious or innocuous stimuli, and then watch the results when different neurons were activated or silenced.

In the Rube-Goldberg-like schematic above, nerve fibers bringing touch information from the brush of a feather (A) activate a “relay” or interneuron in the dorsal horn (shown in red). The pathway then continues up to the brain (B), activating so-called S1 neurons in the somatosensory cortex (C), shown in green. These neurons go down to the spinal cord (D) and talk to the same interneuron. This feedback amplifies the touch signal, as shown by the green line on the graph (E).

In people (or mice) with neuropathic pain, nerve damage causes the amplified touch signal to be perceived as pain.

“In normal conditions, the touch and pain layers of the spinal cord are strongly separated by inhibitory neurons,” explains Alban Latremoliere, PhD, one of four co-first authors on the paper. “After nerve injury, this inhibition is lost, leading to touch information activating pain neurons. When the spinal neurons that are supposed to be pain-only send this information to the brain, we feel pain.”

Dialing down neuropathic pain?

descending neurons from the brain could be part of neuropathic painTOUCH AMPLIFIERS: S1 neurons descending from the somatosensory cortex down toward the spinal cord’s dorsal horns, where they activate the same neurons that receive tactile information from the body. (CREDIT: YUANYUAN LIU/BOSTON CHILDREN’S HOSPITAL)

The investigators think the S1 cortical neurons potentially be targeted to treat the tactile component of neuropathic pain, via drugs or possibly brain electrical stimulation. The goal would be to break the feedback loop that introduces and exaggerates the pain response to normally non-painful touch.

When the team severed the S1 neurons or silenced them genetically in the mouse model, the mice stopped recoiling from light, innocuous touches. Yet the mice retained their sensitivity to truly painful stimuli, reflexively withdrawing their paws when exposed to heat, cold or pinpricks.

He suggests that electrostimulation might be a way to modulate these circuits. Clinicians have tried brain electrostimulation to treat neuropathic pain, but not always successfully.

“Our findings might help us target the stimulation to particular areas or groups of neurons,” He says. “It might be interesting to look at the clinical data and try to replicate the stimulation in animals, and see what kind of stimulation would silence these neurons.”

With functional imaging technologies, investigators could probe what kinds of interventions maximally inhibit this circuit, adds Woolf.

“We now have the ability to silence or activate whole groups of neurons and image their patterns of electrical firing with single-neuron resolution,” he says. “None of this was possible 10 years ago.”

Yuanyuan Liu, Alban Latremoliere and Zicong Zhang (Boston Children’s Hospital) and Xinjian Li (NIMH) were co-first authors on the paper. (Latremoliere is now at Johns Hopkins Medical School.) For a full list of authors and funders, see the paper.

More from the F.M. Kirby Neurobiology Center